India Pharma Outlook Team | Friday, 28 August 2026
India is seeing an H1N1 surge, and flu vaccine demand has jumped sharply as influenza cases rise across the country. Vaccine sales are now nearly three times higher than last year.
The demand has also more than doubled compared with July. Several cities are facing supply constraints as more people seek vaccination.
The rise comes during the monsoon season, when H1N1 and other influenza infections have increased. Cases have reportedly risen more than six-fold compared with previous years.
Digital healthcare platforms are seeing stronger demand from both individuals and companies. People are increasingly choosing convenient vaccination services at home.
Tata 1mg, Apollo Homecare, and PharmEasy have introduced at-home flu vaccination services. Users can book appointments and receive vaccines from trained nurses at home.
Manisha Mishra, Vice-President and lead of Specialty Pharma at Tata 1mg, said demand is about three times higher across major cities.
She attributed the increase to greater awareness among doctors and patients. The wider spread of influenza has also pushed more people to seek protection.
The recently updated 2026-27 flu vaccine is another factor behind the increase. The vaccine has been updated based on World Health Organization recommendations.
The update helps cover newer and evolving influenza strains. Experts say this is important because flu viruses change over time.
Also Read: Delhi Records 138 New H1N1 Cases as Tally Reaches 2,446
The rise in infections is creating demand for rapid molecular diagnostics across India. Molbio Diagnostics is seeing a steady increase in orders for influenza testing solutions. These tests cover influenza A, influenza B, and subtypes such as H3.
Kuldeep Singh Sachdeva, President and Chief Medical Officer at Molbio Diagnostics, said demand is increasing beyond North India. Testing demand is also growing in tier-2 and tier-3 cities. This shows that the need for faster diagnosis is spreading across healthcare markets.
One challenge is that influenza can resemble other illnesses. H1N1, dengue, typhoid, and seasonal flu can cause similar symptoms.These include fever, cough, body ache, and fatigue. Testing can help doctors identify the illness and guide treatment faster.
Anurag Agrawal, Dean of Biosciences and Health Research at Ashoka University, recommends annual flu vaccination. He also advised people to follow basic precautions. These include wearing masks in crowded places and maintaining respiratory hygiene.
Good ventilation, avoiding overcrowding, and regular handwashing can also help reduce infection risks. Rajiv Bahl, Director General of the Indian Council of Medical Research, said there is no need for panic.
Seasonal influenza is generally mild. However, older people, young children, people with underlying conditions, and those with weaker immunity face a higher risk of complications. The current influenza cases are therefore driving both preventive healthcare and diagnostic demand. The trend is also changing how people access vaccines and testing services across India.
.jpg)
